Combining CAR T cells with existing immunotherapies may overcome resistance in glioblastomas – Science Daily
Medical Xpress |
Combining CAR T cells with existing immunotherapies may overcome resistance in glioblastomas
Science Daily Over the past two years, investigators from the Perelman School of Medicine at the University of Pennsylvania have reported results from a human trial in GBM using chimeric antigen receptor (CAR) T cell therapy, through which patients' own T cells were … Human CAR-T Cell Glioblastoma Trial Generates Clues for … |
